Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AMLX

Amylyx Pharmaceuticals, Inc.

CIK 0001658551 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$38.66
↓ 1.00 (-2.52%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$4.31B
P/E Ratio
-28.32
EPS
-1.53
Dividend Yield
Not covered
52W Position
93%
Beta
0.86

Valuation multiples

Fwd P/E
2.77
PEG
Not covered
P/B
18.01
P/S
Not covered
EV/Revenue
Not covered
ROE
-63.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 93%
$7.96$41.14

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$144.74M
Total Assets
$332.64M
Free Cash Flow
-$123.48M

Recent news